AIM
IMGN

Aigen Investment Management’s Immunogen Inc IMGN Stock Holding History

Aigen Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,413
Closed -$83K – 773
2022
Q1 		$83K Sell
17,413
-2,801
-14% -$15.5K 0.01% 500
2021
Q4 		$141K Buy
+20,214
New +$126K 0.01% 969
2021
Q2 		– Sell
-22,916
Closed -$186K – 781
2021
Q1 		$186K Buy
+22,916
New +$187K 0.02% 547
2020
Q1 		– Sell
-82
Closed – – 1644
2019
Q4 		$0 Buy
+82
New +$278 ﹤0.01% 1161

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aigen Investment Management's IMGN Position: Q2 2022 in Review

Aigen Investment Management sold out of Immunogen Inc (IMGN) in Q2 2022, closing a stake of 17,413 shares — an estimated $83K sold.

Aigen Investment Management first reported a position in IMGN in Q4 2019 and held it in 4 quarters. The position peaked at $186K in Q1 2021. 216 funds tracked by Wall St. Rank hold IMGN as of Q2 2022.

  • Aigen Investment Management reported no remaining Immunogen Inc position as of Q2 2022 after selling out during the quarter.
  • Aigen Investment Management sold 17,413 Immunogen Inc shares in Q2 2022, an estimated $83K.
  • Aigen Investment Management first reported a position in Immunogen Inc in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Immunogen Inc position peaked at $186K in Q1 2021.
  • 216 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2022.

Based on Aigen Investment Management's 13F filing for Q2 2022, filed 2 Aug 2022.